Gilgamesh Pharmaceuticals Raises $39 Million To Develop Psychedelic Treatments For Depression Dec 20, 2022
Numinus In Strong Position To Capture US$2.5 Billion Psychedelic-Assisted Therapy Market Dec 20, 2022
